Previous close | 15.15 |
Open | 15.47 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 14.97 - 15.96 |
52-week range | 3.53 - 17.40 |
Volume | |
Avg. volume | 12,858,148 |
Market cap | 2.283B |
Beta (5Y monthly) | 1.62 |
PE ratio (TTM) | N/A |
EPS (TTM) | -3.05 |
Earnings date | 06 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 21.60 |
Whitefort Capital wants biopharmaceutical firm Arbutus to stop issuing stock. Shah Capital ended a proxy campaign against biotech Novavax.
The Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE) to develop bird flu vaccines over increasing fears of widespread transmission of the infection.
After disappointing sales for their Covid vaccines last year, drugmakers are hoping for an August rollout of the updated shot.